iBio
IBIO
#10101
Rank
A$94.25 M
Marketcap
A$1.90
Share price
-2.86%
Change (1 day)
53.28%
Change (1 year)

EPS for iBio (IBIO)

EPS in 2026 (TTM): A-$1.17

According to iBio's latest financial reports the company's current EPS (TTM) is A-$1.05. In 2025 the company made an earnings per share (EPS) of A-$2.44 an increase over its 2024 EPS that were of A-$9.07.

EPS history for iBio from 2007 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$1.17-51.98%
2025A-$2.44-73.08%
2024A-$9.07-93.88%
2023A-$148.15-8.14%
2022A-$161.2792.67%
2021A-$83.71-80.33%
2020A-$425.51-35.11%
2019A-$655.70-38.96%
2018A-$1,074-6.1%
2017A-$1,14436.67%
2016A-$837.0633.33%
2015A-$627.7950%
2014A-$418.53-53.85%
2013A-$906.81-7.14%
2012A-$976.57-64.1%
2011A-$2,72077.27%
2010A-$1,535144.44%
2009A-$627.7912.93%
2008A-$555.9312.2%
2007A-$495.48

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$12.19-1,264.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Genocea Biosciences
GNCA
A-$0.73-30.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
A-$11.75 1,022.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A-$0.24-77.33%๐Ÿ‡บ๐Ÿ‡ธ USA